NL189563C - Pyridyl-aminoalkyl-ethers alsmede farmaceutische preparaten daarvan die werkzaam zijn tegen hartritmestoornissen. - Google Patents
Pyridyl-aminoalkyl-ethers alsmede farmaceutische preparaten daarvan die werkzaam zijn tegen hartritmestoornissen.Info
- Publication number
- NL189563C NL189563C NLAANVRAGE7802719,A NL7802719A NL189563C NL 189563 C NL189563 C NL 189563C NL 7802719 A NL7802719 A NL 7802719A NL 189563 C NL189563 C NL 189563C
- Authority
- NL
- Netherlands
- Prior art keywords
- pyridyl
- pharmaceutical preparations
- effective against
- against heart
- aminoalkyl ethers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C2204/00—Features not otherwise provided for
- A61C2204/002—Features not otherwise provided for using batteries
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772711655 DE2711655A1 (de) | 1977-03-17 | 1977-03-17 | Pyridinyl-aminoalkylaether |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7802719A NL7802719A (nl) | 1978-09-19 |
| NL189563B NL189563B (nl) | 1992-12-16 |
| NL189563C true NL189563C (nl) | 1993-05-17 |
Family
ID=6003884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7802719,A NL189563C (nl) | 1977-03-17 | 1978-03-13 | Pyridyl-aminoalkyl-ethers alsmede farmaceutische preparaten daarvan die werkzaam zijn tegen hartritmestoornissen. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4206117A (bg) |
| JP (1) | JPS53116382A (bg) |
| AT (2) | AT364360B (bg) |
| AU (1) | AU525566B2 (bg) |
| BE (1) | BE864917A (bg) |
| CA (1) | CA1108148A (bg) |
| CH (1) | CH638186A5 (bg) |
| CS (2) | CS202011B2 (bg) |
| DD (1) | DD134090A5 (bg) |
| DE (1) | DE2711655A1 (bg) |
| DK (1) | DK118578A (bg) |
| ES (1) | ES467931A1 (bg) |
| FI (1) | FI74962C (bg) |
| FR (1) | FR2383930A1 (bg) |
| GB (1) | GB1599061A (bg) |
| GR (1) | GR64096B (bg) |
| HU (1) | HU177287B (bg) |
| IE (1) | IE46484B1 (bg) |
| IL (1) | IL54265A0 (bg) |
| IT (1) | IT1093796B (bg) |
| LU (1) | LU79235A1 (bg) |
| NL (1) | NL189563C (bg) |
| NO (1) | NO150605C (bg) |
| SE (1) | SE446185B (bg) |
| SU (2) | SU799658A3 (bg) |
| YU (2) | YU63678A (bg) |
| ZA (1) | ZA781552B (bg) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474781A (en) * | 1979-04-02 | 1984-10-02 | Merck & Co., Inc. | Treating hypertension with aminoalkoxypyridines |
| DE3008522A1 (de) * | 1980-03-06 | 1981-09-17 | Basf Ag, 6700 Ludwigshafen | 4-(alpha)-cycloamino-arylmethyl-6-methyl-1,3-dihydro-furo (3,4-c) -pyridin-7-ole, ihre herstellung und verwendung |
| IL62602A (en) * | 1980-05-19 | 1984-06-29 | Labaz Sanofi Nv | Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them |
| JPS588066A (ja) * | 1981-07-03 | 1983-01-18 | Otsuka Pharmaceut Co Ltd | 光学活性〔ｓ〕−（−）−カルボスチリル誘導体の製造法 |
| EP0097000B1 (en) * | 1982-06-10 | 1987-09-09 | Beecham Wuelfing GmbH & Co KG | Amine derivatives |
| DE3519693A1 (de) * | 1985-06-01 | 1987-01-02 | Basf Ag | Pyridin-derivate, ihre herstellung und verwendung |
| GB8603475D0 (en) * | 1986-02-12 | 1986-03-19 | Glaxo Group Ltd | Chemical compounds |
| GB8703007D0 (en) * | 1987-02-10 | 1987-03-18 | Glaxo Group Ltd | Chemical compounds |
| GB9012926D0 (en) * | 1990-06-09 | 1990-08-01 | Scras | Pyrrolo-pyridine derivatives |
| ES2245660T3 (es) * | 1990-11-30 | 2006-01-16 | Otsuka Pharmaceutical Co., Ltd. | Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos. |
| MY128323A (en) | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
| US20010034357A1 (en) * | 2000-02-02 | 2001-10-25 | Nan-Horng Lin | Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| US20070208026A1 (en) * | 2003-04-07 | 2007-09-06 | Liu Kevin | N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| PT3135672T (pt) | 2008-10-10 | 2020-04-02 | Vm Discovery Inc | Composições e métodos para o tratamento distúrbios de utilização de álcool, dor e outras doenças |
| KR101698153B1 (ko) * | 2010-04-26 | 2017-01-23 | 광주과학기술원 | Ｐ2ｘ1 및 ｐ2ｘ3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1572768A (en) * | 1925-06-26 | 1926-02-09 | Winthrop Chem Co Inc | Pharmaceutical product |
| US1881236A (en) * | 1929-08-10 | 1932-10-04 | Soc Of Chemical Ind | Basic ethers of the pyridine series |
| US3535328A (en) * | 1967-09-01 | 1970-10-20 | Exxon Research Engineering Co | Certain substituted aminothioethoxy pyridines |
| US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
| AR206801A1 (es) * | 1973-02-20 | 1976-08-23 | Ciba Geigy Ag | Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano |
| US4073909A (en) * | 1973-10-08 | 1978-02-14 | Sandoz Ltd. | Isoquinoline compounds |
| CH592625A5 (bg) * | 1974-05-14 | 1977-10-31 | Ciba Geigy Ag | |
| CH614711A5 (bg) * | 1975-04-08 | 1979-12-14 | Sandoz Ag | |
| GB1504424A (en) * | 1975-08-09 | 1978-03-22 | Beecham Group Ltd | Isoquinoline-derived aminoethers |
| GB1485919A (en) | 1975-08-12 | 1977-09-14 | Grindstedvaerket As | Pyridine derivatives |
| US4060601A (en) * | 1976-06-15 | 1977-11-29 | Merck & Co., Inc. | Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines |
-
1977
- 1977-03-17 DE DE19772711655 patent/DE2711655A1/de active Granted
-
1978
- 1978-02-25 GR GR55546A patent/GR64096B/el unknown
- 1978-03-09 GB GB9334/78A patent/GB1599061A/en not_active Expired
- 1978-03-10 IT IT21099/78A patent/IT1093796B/it active
- 1978-03-10 US US05/885,434 patent/US4206117A/en not_active Expired - Lifetime
- 1978-03-13 IE IE503/78A patent/IE46484B1/en unknown
- 1978-03-13 IL IL54265A patent/IL54265A0/xx not_active IP Right Cessation
- 1978-03-13 NL NLAANVRAGE7802719,A patent/NL189563C/xx not_active IP Right Cessation
- 1978-03-14 CH CH278478A patent/CH638186A5/de not_active IP Right Cessation
- 1978-03-14 SE SE7802927A patent/SE446185B/sv not_active IP Right Cessation
- 1978-03-14 FR FR7807262A patent/FR2383930A1/fr active Granted
- 1978-03-15 BE BE185950A patent/BE864917A/xx not_active IP Right Cessation
- 1978-03-15 DD DD78204190A patent/DD134090A5/xx unknown
- 1978-03-15 SU SU782589450A patent/SU799658A3/ru active
- 1978-03-15 LU LU79235A patent/LU79235A1/de unknown
- 1978-03-16 CA CA299,068A patent/CA1108148A/en not_active Expired
- 1978-03-16 DK DK118578A patent/DK118578A/da unknown
- 1978-03-16 HU HU78BA3641A patent/HU177287B/hu not_active IP Right Cessation
- 1978-03-16 ES ES467931A patent/ES467931A1/es not_active Expired
- 1978-03-16 CS CS781680A patent/CS202011B2/cs unknown
- 1978-03-16 YU YU00636/78A patent/YU63678A/xx unknown
- 1978-03-16 NO NO780931A patent/NO150605C/no unknown
- 1978-03-16 CS CS787593A patent/CS202012B2/cs unknown
- 1978-03-16 ZA ZA00781552A patent/ZA781552B/xx unknown
- 1978-03-16 AU AU34195/78A patent/AU525566B2/en not_active Expired
- 1978-03-16 AT AT0187878A patent/AT364360B/de not_active IP Right Cessation
- 1978-03-17 JP JP3004178A patent/JPS53116382A/ja active Granted
- 1978-03-17 FI FI780842A patent/FI74962C/fi not_active IP Right Cessation
- 1978-12-19 SU SU782699099A patent/SU850002A3/ru active
-
1980
- 1980-02-15 AT AT0084080A patent/AT364361B/de not_active IP Right Cessation
-
1982
- 1982-10-07 YU YU2252/82A patent/YU41016B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO781786L (no) | Terapeutisk middel. | |
| BE871584A (fr) | Preparations pharmaceutiques | |
| NL7801187A (nl) | Farmaceutisch tablet. | |
| IT1192585B (it) | Polisaccaride avente attivita' anti-tumorale,procedimento per la sua produzione e sostanza anti-tumorale comprendente detto polisaccaride | |
| NL188078C (nl) | Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen. | |
| NL190552C (nl) | 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten. | |
| NL189563C (nl) | Pyridyl-aminoalkyl-ethers alsmede farmaceutische preparaten daarvan die werkzaam zijn tegen hartritmestoornissen. | |
| NL7803162A (nl) | Nieuwe 1-aminoindaanderivaten, alsmede farmaceutische preparaten die deze bevatten. | |
| NO783971L (no) | Hudpleiepreparat. | |
| NL950027I2 (nl) | Alfa-halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat die dit bevat. | |
| NL187397C (nl) | Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding. | |
| NL7903769A (nl) | Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan. | |
| NL7801921A (nl) | Farmaceutische preparaten. | |
| NL7804887A (nl) | Bisamidine-verbindingen, hun bereiding, en farmaceuti- sche mengsels die hen bevatten. | |
| SE7809887L (sv) | Terapeutiska medel | |
| IT7825570A0 (it) | Sostanza antitumorale eprocedimento per la sua preparazione. | |
| CH611768A5 (en) | Ground-hugging harrow, especially for the upkeep of meadows and pastures | |
| DZ276A1 (fr) | Préparations pharmaceutiques. | |
| MC1371A1 (fr) | Preparations pharmaceutiques | |
| NL184896C (nl) | Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten. | |
| NL7704084A (nl) | Medicinale preparaten. | |
| NL174646C (nl) | 6,7-dimethoxy-4-amino-2-piperidinochinazolinen en farmaceutische preparaten die ze bevatten. | |
| NL7802869A (nl) | Anti-histamine-stoffen en preparaten die ze be- vatten. | |
| NL7803574A (nl) | Nieuwe thenoylindaanderivaten en farmaceutische prepa- raten die deze derivaten bevatten. | |
| NL7802417A (nl) | Tandverzorgingsprodukt. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| A85 | Still pending on 85-01-01 | ||
| BC | A request for examination has been filed | ||
| V2 | Lapsed due to non-payment of the last due maintenance fee for the patent application |